This article analyses the EU approach to health information technology and mobile medical applications, and the emerging rules and compliance issues for companies developing and marketing these products. In particular, it examines the EU approach to regulation and outlines significant developments and differences in major European markets.

This article is part of the global guide to life sciences. For a full list of jurisdictional Q&As visit www.practicallaw.com/lifesciences-guide.